問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taichung Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2011-01-01 - 2017-12-31
Condition/Disease
Postoperative adjuvant therapy for hepatitis virus-related liver cancer
Test Drug
PI-88 or matching placebo
Participate Sites9Sites
Terminated9Sites
2017-12-01 - 2018-12-20
Adjuvant treatment of Post- Resection Hepatocellular Carcinoma
Muparfostat (PI-88)
Participate Sites10Sites
Terminated8Sites
Study ended1Sites
Division of Others-
2008-05-01 - 2012-05-31
Participate Sites11Sites
Terminated11Sites
2007-03-01 - 2008-12-31
Participate Sites12Sites
Terminated12Sites
2006-03-01 - 2012-03-31
Participate Sites3Sites
Study ended3Sites
2006-03-01 - 2012-03-01
Participate Sites4Sites
Study ended4Sites
2008-02-01 - 2010-09-01
Terminated4Sites
2007-12-25 - 2009-09-30
2007-05-01 - 2009-12-31
Study ended11Sites
2017-10-06 - 2022-10-15
Relapse or Refractory Multiple Myeloma
POMALYST
Participate Sites2Sites
Not yet recruiting2Sites
全部
